top of page
< Back

CA

RFA-AR-25-013

Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)

The Regenerative Medicine Innovation Project (RMIP) funds scientists to explore new ideas in regenerative medicine—ways to repair, replace, or regrow human cells, tissues, or organs. This program supports investigator-initiated studies, meaning researchers propose their own projects rather than following a set plan. Clinical trials are not allowed in this funding. The goal is to encourage creative, early-stage research that could lead to new treatments or breakthroughs in regenerative medicine.

Full Description

regenerative medicine innovation project (rmip) investigator-initiated studies (u01 clinical trial not allowed)

If you want to feel more confident about your application, we're here. Reach out anytime!

Agency:

Contact:

Deadline:

National Institutes of Health

2025-10-21

bottom of page